The Prevention of Diabetic Cardiomyopathy by Non-Mitogenic Acidic Fibroblast Growth Factor Is Probably Mediated by the Suppression of Oxidative Stress and Damage

• Chi Zhang,

  Affiliations Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical University, Wenzhou, Zhejiang, China, Ruian Center of the Chinese-American Research Institute for Diabetic Complications, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

  ⨯
• Linbo Zhang,

  Affiliations Department of Pathology, Western University, London, Ontario, Canada, Department of Pharmaceutical Engineering, Jilin Agriculture University, Changchun, Jilin, China

  ⨯
• Shali Chen,

  Affiliation Department of Pathology, Western University, London, Ontario, Canada

  ⨯
• Biao Feng,

  Affiliation Department of Pathology, Western University, London, Ontario, Canada

  ⨯
• Xuemian Lu,

  Affiliation Ruian Center of the Chinese-American Research Institute for Diabetic Complications, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

  ⨯
• Yang Bai,

  Affiliation Department of Cardiac Surgery, The First Hospital of Jilin University, Changchun, Jilin, China

  ⨯
• Guang Liang,

  Affiliations Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical University, Wenzhou, Zhejiang, China, School of Pharmacy, Wenzhou Medical University, Wenzhou, Zhejiang, China

  ⨯
• Yi Tan,

  Affiliations Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical University, Wenzhou, Zhejiang, China, Departments of Pharmacology and Toxicology, University of Louisville, Louisville, Kentucky, United States of America, Kosair Children's Hospital Research Institute, Department of Pediatrics, University of Louisville, Louisville, Kentucky, United States of America

  ⨯
• Minglong Shao,

  Affiliations Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical University, Wenzhou, Zhejiang, China, Ruian Center of the Chinese-American Research Institute for Diabetic Complications, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

  ⨯
• Melissa Skibba,

  Affiliation Departments of Pharmacology and Toxicology, University of Louisville, Louisville, Kentucky, United States of America

  ⨯
• Litai Jin,

  Affiliations Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical University, Wenzhou, Zhejiang, China, School of Pharmacy, Wenzhou Medical University, Wenzhou, Zhejiang, China

  ⨯
• Xiaokun Li,

  Affiliations Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical University, Wenzhou, Zhejiang, China, Department of Cardiac Surgery, The First Hospital of Jilin University, Changchun, Jilin, China

  ⨯
• Subrata Chakrabarti ,

  * E-mail: l0cai001@louisville.edu (LC); subrata.chakrabarti@lhsc.on.ca (SC)

  Affiliation Department of Pathology, Western University, London, Ontario, Canada

  ⨯
• Lu Cai

  * E-mail: l0cai001@louisville.edu (LC); subrata.chakrabarti@lhsc.on.ca (SC)

  Affiliations Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical University, Wenzhou, Zhejiang, China, Departments of Pharmacology and Toxicology, University of Louisville, Louisville, Kentucky, United States of America, Kosair Children's Hospital Research Institute, Department of Pediatrics, University of Louisville, Louisville, Kentucky, United States of America

  ⨯